NCT01490944

Brief Summary

The study is a clinical trial to assess the effectiveness of Vitamin B12 supplementation along with Iron Folic Acid (IFA) in combating anaemia. Adolescent anaemic girls will be randomly divided into two groups.

  • Group 1: IFA weekly supplementation along with Information, Education, Communication sessions
  • Group 2: IFA + Cyanocobalamin weekly supplementation along with Information, Education, Communication sessions Duration of supplementation: 6 months

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
360

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Jan 2012

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 11, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 13, 2011

Completed
19 days until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2013

Completed
Last Updated

February 28, 2012

Status Verified

January 1, 2012

Enrollment Period

10 months

First QC Date

December 11, 2011

Last Update Submit

February 25, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in hemoglobin level

    The primary outcome would be to assess the change in hemoglobin level after intervention with Iron Folic acid \& cyanocobalamin weekly supplementation for 6 months and to compare the results with the group 1 in which only Iron and Folic acid would be supplemented

    at baseline and after 6 months

Secondary Outcomes (1)

  • Change in serum ferritin, folic acid and vitamin B12 levels

    at baseline and at end of 6 months

Study Arms (2)

Iron and Folic Acid

ACTIVE COMPARATOR
Drug: Iron and Folic Acid

Iron, Folic acid and cyanocobalamin

EXPERIMENTAL
Drug: Iron, Folic acid and Cyanocobalamin

Interventions

Total duration= 6 months Iron=100 mg, Folic acid= 500 mcg, Cyanocobalamin 500 mcg weekly supplementation in the form of capsule for 6 weeks Iron=100 mg, Folic acid= 500 mcg, Cyanocobalamin 15 mcg weekly supplementation in the form of capsule for next 20 weeks

Iron, Folic acid and cyanocobalamin

Iron= 100 mg, Folic acid= 500 mcg weekly supplementation in the form of capsule for 6 months

Iron and Folic Acid

Eligibility Criteria

Age11 Years - 18 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Willingness to participate
  • Unmarried or married (who still reside with their parents, i.e. prior to 'Gauna') adolescent girl.

You may not qualify if:

  • Severe anaemia
  • Pregnant Adolescent girls
  • Medical conditions like TB, Cancer etc

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kirti Nagar Slums

New Delhi, National Capital Territory of Delhi, 110015, India

RECRUITING

Related Publications (15)

  • Basu RN, Sood SK, Ramachandran K, Mathur M, Ramalingaswami V. Etiopathogenesis of nutritional anemia in pregnancy: a therapeutic approach. Am J Clin Nutr. 1973 Jun;26(6):591-4. doi: 10.1093/ajcn/26.6.591. No abstract available.

    PMID: 4575153BACKGROUND
  • Sood SK, Ramachandran K, Mathur M, Gupta K, Ramalingaswamy V, Swarnabai C, Ponniah J, Mathan VI, Baker SJ. W.H.O. sponsored collaborative studies on nutritional anaemia in India. 1. The effects of supplemental oral iron administration to pregnant women. Q J Med. 1975 Apr;44(174):241-58.

    PMID: 1103213BACKGROUND
  • Gomber S, Agarwal KN, Mahajan C, Agarwal N. Impact of daily versus weekly hematinic supplementation on anemia in pregnant women. Indian Pediatr. 2002 Apr;39(4):339-46.

    PMID: 11976463BACKGROUND
  • Kotecha PV, Nirupam S, Karkar PD. Adolescent girls' Anaemia Control Programme, Gujarat, India. Indian J Med Res. 2009 Nov;130(5):584-9.

    PMID: 20090111BACKGROUND
  • Agarwal KN, Gomber S, Bisht H, Som M. Anemia prophylaxis in adolescent school girls by weekly or daily iron-folate supplementation. Indian Pediatr. 2003 Apr;40(4):296-301.

    PMID: 12736400BACKGROUND
  • Bruner AB, Joffe A, Duggan AK, Casella JF, Brandt J. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet. 1996 Oct 12;348(9033):992-6. doi: 10.1016/S0140-6736(96)02341-0.

    PMID: 8855856BACKGROUND
  • Ahmed F, Khan MR, Akhtaruzzaman M, Karim R, Marks GC, Banu CP, Nahar B, Williams G. Efficacy of twice-weekly multiple micronutrient supplementation for improving the hemoglobin and micronutrient status of anemic adolescent schoolgirls in Bangladesh. Am J Clin Nutr. 2005 Oct;82(4):829-35. doi: 10.1093/ajcn/82.4.829.

    PMID: 16210713BACKGROUND
  • Deshmukh PR, Garg BS, Bharambe MS. Effectiveness of weekly supplementation of iron to control anaemia among adolescent girls of Nashik, Maharashtra, India. J Health Popul Nutr. 2008 Mar;26(1):74-8.

    PMID: 18637530BACKGROUND
  • Sen A, Kanani SJ. Impact of iron-folic acid supplementation on cognitive abilities of school girls in Vadodara. Indian Pediatr. 2009 Feb;46(2):137-43.

    PMID: 19242031BACKGROUND
  • Shobha S, Sharada D. Efficacy of twice weekly iron supplementation in anemic adolescent girls. Indian Pediatr. 2003 Dec;40(12):1186-90.

    PMID: 14722370BACKGROUND
  • Singla PN, Bhardwaj B, Agarwal DK, Agarwal KN. Vitamin B12 and folic acid in preschool anemia. Indian Pediatr. 1985 Jan;22(1):27-33. No abstract available.

    PMID: 4077257BACKGROUND
  • Singla PN, Gupta HP, Ahuja C, Agarwal KN. Deficiency anaemias in preschool children--estimation of prevalence based on response to haematinic supplementation. J Trop Pediatr. 1982 Apr;28(2):77-80. doi: 10.1093/tropej/28.2.77. No abstract available.

    PMID: 6763946BACKGROUND
  • Mozaffari-Khosravi H, Noori-Shadkam M, Fatehi F, Naghiaee Y. Once weekly low-dose iron supplementation effectively improved iron status in adolescent girls. Biol Trace Elem Res. 2010 Jun;135(1-3):22-30. doi: 10.1007/s12011-009-8480-0. Epub 2009 Aug 4.

    PMID: 19652922BACKGROUND
  • Hettiarachchi M, Liyanage C, Wickremasinghe R, Hilmers DC, Abrams SA. The efficacy of micronutrient supplementation in reducing the prevalence of anaemia and deficiencies of zinc and iron among adolescents in Sri Lanka. Eur J Clin Nutr. 2008 Jul;62(7):856-65. doi: 10.1038/sj.ejcn.1602791. Epub 2007 May 16.

    PMID: 17522609BACKGROUND
  • Worthington-White DA, Behnke M, Gross S. Premature infants require additional folate and vitamin B-12 to reduce the severity of the anemia of prematurity. Am J Clin Nutr. 1994 Dec;60(6):930-5. doi: 10.1093/ajcn/60.6.930.

    PMID: 7985636BACKGROUND

MeSH Terms

Conditions

Anemia

Interventions

IronFolic AcidVitamin B 12

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Metals, HeavyElementsInorganic ChemicalsTransition ElementsMetalsPterinsPteridinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsCorrinoidsTetrapyrrolesPyrrolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic Compounds, 4 or More RingsMacrocyclic CompoundsPolycyclic Compounds

Study Officials

  • Dr. Gurdayal S Toteja, Ph.D

    Indian Council of Medical Research

    PRINCIPAL INVESTIGATOR
  • Priyanka Gupta, M.Sc

    Indian Council of Medical Research

    PRINCIPAL INVESTIGATOR
  • Dr. Neena Bhatia, Ph.D

    Delhi University

    PRINCIPAL INVESTIGATOR
  • Dr. Naval K Vikram, M.D.

    All India Institute of Medical Sciences

    PRINCIPAL INVESTIGATOR
  • Dr. Anupa Siddhu, Ph.D

    Delhi University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dr. Gurdayal S Toteja, Ph.D

CONTACT

Priyanka Gupta, M.Sc

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Scientist-F (Deputy Director General, Senior Grade) and Principal Investigator

Study Record Dates

First Submitted

December 11, 2011

First Posted

December 13, 2011

Study Start

January 1, 2012

Primary Completion

November 1, 2012

Study Completion

January 1, 2013

Last Updated

February 28, 2012

Record last verified: 2012-01

Locations